Cryosite Limited (ASX:CTE) Insider Mark Kerr Acquires 1,000,000 Shares

Cryosite Limited (ASX:CTE) insider Mark Kerr purchased 1,000,000 shares of the business’s stock in a transaction on Tuesday, April 23rd. The shares were acquired at an average price of A$0.83 ($0.55) per share, with a total value of A$830,000.00 ($546,052.63).

Cryosite Stock Performance

The company has a debt-to-equity ratio of 87.26, a quick ratio of 1.76 and a current ratio of 2.32.

About Cryosite

Cryosite Limited offers outsourced clinical trials logistic services in Australia. It operates through two segments, Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological, as well as logistics services to the clinical trials, research, and pharmaceutical industries.